(Q35553741)

English

Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations

scientific article published on 5 August 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Crohn's disease

0 references

Marco Matucci-Cerinic

12

object named as

Matucci-Cerinic M

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Roberto Giacomelli

2

object named as

Giacomelli R

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

author name string

Generini S

1

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Fedi R

3

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Fulminis A

4

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Pignone A

5

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Frieri G

6

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Del Rosso A

7

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Viscido A

8

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Galletti B

9

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Fazzi M

10

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Tonelli F

11

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

language of work or name

0 references

publication date

5 August 2004

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

63

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1664-1669

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754868

27 July 2018

Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754868

27 July 2018

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754868

27 July 2018

Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754868

27 July 2018

Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754868

27 July 2018

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754868

27 July 2018

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754868

27 July 2018

Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754868

27 July 2018

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754868

27 July 2018

Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754868

27 July 2018

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754868

27 July 2018

The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754868

27 July 2018

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754868

27 July 2018

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754868

26 September 2018

Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754868

26 September 2018

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754868

26 September 2018

Enthesitis and ankylosis in spondyloarthropathy: what is the target of the immune response?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754868

26 September 2018

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754868

26 September 2018

Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives

1 reference

https://pubmed.ncbi.nlm.nih.gov/15297279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infliximab treatment of severe ankylosing spondylitis: one-year followup

1 reference

https://pubmed.ncbi.nlm.nih.gov/15297279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15297279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/15297279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement of arthritis and arthralgia after treatment with infliximab (Remicade) in a German prospective, open-label, multicenter trial in refractory Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15297279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infliximab in ankylosing spondylitis: a prospective observational inception cohort analysis of efficacy and safety

1 reference

https://pubmed.ncbi.nlm.nih.gov/15297279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical use of Infliximab in Crohn's disease: the Edinburgh experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/15297279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Musculoskeletal manifestations in inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15297279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ARD.2003.012450

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35553741&oldid=1579015940"